The medical news section is back! We know you have been waiting for it. The medical equipment company Loran has prepared interesting news from the medical world that we are interested in. We are sure you will like them too.
The first robotic lung transplant in Spain
A 65-year-old man with pulmonary fibrosis underwent a robotic lung transplant. The Da Vinci robot allowed surgeons in Barcelona to perform less invasive lung surgery, reduced the size of the incision, and avoided breaking bones. Before the operation, the air was removed from the donor's lung to reduce its size, and as a result, the organ was placed in the chest through a small incision - only 8 cm wide.
Moderna vaccine reduces the likelihood of melanoma recurrence by 44%
One of the strategic directions of medical research in the 21st century is the development of personalized anti-cancer vaccines. Currently, the Moderna mRNA vaccine is at the forefront of this field, which can significantly reduce the risk of recurrence of melanoma, one of the most dangerous types of dermatological cancer.
According to the American Association for Cancer Research, adding a personalized mRNA vaccine to Merck's immunotherapy can reduce the risk of recurrence by 44% compared to conventional immunotherapy.
By the way, Loran's product range includes the ILLUCO IDS-1100 polarizing dermatoscope, which helps doctors recognize melanoma at an early stage.
Modified stem cells will help restore the heart after a heart attack
Modified stem cells may be the key to restoring the heart after a heart attack, according to scientists from Italy and the United States. Clinical trials using engineered stem cells have successfully restored cardiac function in patients after a heart attack.
Although heart cell transplantation has great potential for treating patients, it can be accompanied by a difficult transition period that includes heart rhythm disturbances such as arrhythmias. However, scientists have discovered a molecular mechanism that leads to incompatibility between transplanted cells and adult heart cells and has developed gene editing methods to help avoid this problem.
Discovery: a new autoinflammatory disease damages the liver
Scientists at the National Institute of Allergy and Infectious Diseases (USA) have reported the discovery of a new autoinflammatory disease called LAVLI.
This disease damages the liver and can lead to the development of liver fibrosis, which can cause hepatic ischemia and failure.
The effectiveness of the new malaria vaccine has exceeded 75%
Scientists at the University of Oxford have developed a new R-21/Matrix-M malaria vaccine that is more than 75% effective, exceeding the threshold set by the World Health Organization (WHO). This vaccine has been approved for use in Ghana and is the second malaria vaccine to be approved worldwide.
What makes the new vaccine special is that it can be produced on a large scale at a low cost, making it available for hundreds of millions of doses in African countries where malaria is a serious problem.
If you liked this article, please share it on social media by tagging Loran. We will be very grateful for the popularization of science.
